Associated Papers
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.
Poussin K et al.
Oncoimmunology, 2013
24501689 (PubMed )
Supplement: onci-2-e27090-s01.pdf
Select a paper to view details